 MALVERN, Pa., Nov. 28, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. Ocugen or the Company NASDAQ: OCGN, a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Companys Chief Scientific Officer, Arun Upadhyay, Ph.D., will participate in the 3 rd Annual Dry AMD Therapeutics Summit at the Revere Hotel in Boston, Mass. from November 30-December 2, 2022. 